[go: up one dir, main page]

AR037909A1 - Composiciones de formulaciones para lactantes que comprenden cantidades incrementadas de alfa-lactalbumina - Google Patents

Composiciones de formulaciones para lactantes que comprenden cantidades incrementadas de alfa-lactalbumina

Info

Publication number
AR037909A1
AR037909A1 ARP020104954A ARP020104954A AR037909A1 AR 037909 A1 AR037909 A1 AR 037909A1 AR P020104954 A ARP020104954 A AR P020104954A AR P020104954 A ARP020104954 A AR P020104954A AR 037909 A1 AR037909 A1 AR 037909A1
Authority
AR
Argentina
Prior art keywords
infants
formulations
lactalbumina
alfa
compositions
Prior art date
Application number
ARP020104954A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23345331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR037909(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR037909A1 publication Critical patent/AR037909A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Una composición de formulaciones para lactantes que comprende una fracción de suero en la cual el 40% o menos de la proteína total en dicha fracción es alfa-lactalbúmina y mas de 8% de la proteína total en dicha fracción de suero es beta-lactoglobulina con la condición de que el porcentaje de alfa-lactalbúmina en dicha fracción de suero sea superior al porcentaje de beta-lactoglobulina en dicha fracción de suero.
ARP020104954A 2001-12-21 2002-12-18 Composiciones de formulaciones para lactantes que comprenden cantidades incrementadas de alfa-lactalbumina AR037909A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34325301P 2001-12-21 2001-12-21

Publications (1)

Publication Number Publication Date
AR037909A1 true AR037909A1 (es) 2004-12-22

Family

ID=23345331

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104954A AR037909A1 (es) 2001-12-21 2002-12-18 Composiciones de formulaciones para lactantes que comprenden cantidades incrementadas de alfa-lactalbumina

Country Status (28)

Country Link
US (1) US6913778B2 (es)
EP (1) EP1455585B1 (es)
JP (1) JP4317455B2 (es)
KR (1) KR100955408B1 (es)
CN (2) CN100456936C (es)
AR (1) AR037909A1 (es)
AT (1) ATE439044T1 (es)
AU (1) AU2002357354B2 (es)
BR (1) BR0215198A (es)
CA (1) CA2471423C (es)
CO (1) CO5590862A2 (es)
CY (1) CY1109503T1 (es)
DE (1) DE60233346D1 (es)
DK (1) DK1455585T3 (es)
EA (1) EA007148B1 (es)
EC (1) ECSP045154A (es)
ES (1) ES2329667T3 (es)
IL (2) IL162244A0 (es)
MX (1) MXPA04005887A (es)
NO (1) NO20043108L (es)
NZ (1) NZ534041A (es)
PL (1) PL371379A1 (es)
PT (1) PT1455585E (es)
SG (1) SG169897A1 (es)
TW (1) TWI301052B (es)
UA (1) UA81903C2 (es)
WO (1) WO2003055322A1 (es)
ZA (1) ZA200405777B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7651716B2 (en) * 2001-12-21 2010-01-26 Wyeth Llc Methods for reducing adverse effects of feeding formula to infants
EP1549158B1 (en) * 2002-10-10 2009-01-07 Wyeth Infant formula containing nucleotides
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
US20080089981A1 (en) † 2006-10-17 2008-04-17 N.V. Nutricia Ketogenic diet
EP1932437A1 (en) * 2006-12-15 2008-06-18 Nestec S.A. Infant formula
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
JP5322405B2 (ja) * 2007-06-07 2013-10-23 小林製薬株式会社 タンパク質含有組成物
US8586122B2 (en) * 2007-07-26 2013-11-19 Loders Croklaan Usa Llc Composition suitable for use in baking
JP2010540618A (ja) * 2007-10-02 2010-12-24 アリエル−ユニバーシティー リサーチ アンド デベロップメント カンパニー リミテッド 幼児の成長および発達を増大するための内在性カンナビノイド
EP2282641B1 (en) * 2008-04-29 2012-08-29 DSM IP Assets B.V. Composition comprising carbohydrates and peptides which comprise tryptophan
WO2009132950A1 (en) * 2008-04-29 2009-11-05 Unilever Nv Process for the preparation of packaged heat-preserved aqueous drink comprising casein micelles and tryptophan-rich peptides, and product so obtained
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
CN107646976A (zh) * 2009-10-28 2018-02-02 维利奥有限公司 乳清蛋白产品及其制备方法
CN101831415B (zh) * 2010-05-12 2012-05-30 江苏博立生物制品有限公司 一种提高糖化酶发酵水平的方法
WO2012077076A1 (en) * 2010-12-08 2012-06-14 Holt Patrick G Treating or preventing sensitivity to milk allergens
WO2012091542A1 (en) 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
MX2013007694A (es) * 2010-12-30 2013-08-15 Abbott Lab Tolerancia mejorada en una formula infantil de bajo contenido calorico.
US20120171328A1 (en) * 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
BR112013020108A2 (pt) 2011-02-10 2017-06-13 Nestec Sa modulação do crescimento de bifidobactérias usando uma combinação de oligossacarídeos encontrados no leite de ser humano
FI123267B (fi) * 2011-02-18 2013-01-15 Valio Oy Juusto ja sen valmistus
WO2012147075A1 (en) * 2011-04-28 2012-11-01 Shemen Industries Ltd Vegetable based oil preparation for baked goods
MX389785B (es) 2011-07-26 2025-03-18 Nucitec Sa De Cv Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento.
MX350870B (es) * 2011-11-10 2017-09-22 Nestec Sa Formula para lactantes con alto palmitato sn-2 y oligofructosa.
FI125332B (fi) * 2011-11-11 2015-08-31 Valio Oy Menetelmä maitotuotteen valmistamiseksi
CN102630803A (zh) * 2012-05-15 2012-08-15 东北农业大学 母乳化牛乳蛋白及其制备方法
MX2012010488A (es) * 2012-09-11 2014-03-26 Nucitec Sa De Cv Formula infantil para el optimo crecimiento, proteccion gastrointestinal y proteccion inmunologica de infantes.
MX2012010487A (es) * 2012-09-11 2014-03-26 Nucitec Sa De Cv Composicion de nutrimientos y sustancias bioactivas que favorecen el crecimiento y que disminuyen la intolerancia y los efectos adversos en infantes prematuros.
CN103027116A (zh) * 2012-12-04 2013-04-10 内蒙古伊利实业集团股份有限公司 一种有助于睡眠的奶粉及其制备方法
WO2015154262A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them.
WO2015178761A1 (en) 2014-05-19 2015-11-26 N.V. Nutricia Formulas comprising optimised amino acid profiles
WO2015178762A1 (en) * 2014-05-19 2015-11-26 N.V. Nutricia Enteral formulations for preterm infants comprising optimised phenylalanine intake levels
CN104012657B (zh) * 2014-05-21 2016-04-13 澳优乳业（中国）有限公司 一种氨基酸母乳化婴幼儿配方奶粉及其制备方法
CN104522175A (zh) * 2014-12-29 2015-04-22 光明乳业股份有限公司 一种低敏婴儿配方奶粉的制备及检测方法
MX2018003365A (es) * 2015-09-28 2018-05-30 Nestec Sa Composiciones nutricionales sinteticas especificas de genero, y sistemas nutricionales que las comprenden.
US11122833B1 (en) * 2016-02-26 2021-09-21 Michelle Ann Toothman Infant formulas having vitamin complexes with enhanced bioavailability
US10039765B1 (en) * 2016-02-26 2018-08-07 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
US10039805B1 (en) * 2016-02-26 2018-08-07 Michelle Ann Toothman Infant formulas having vitamin complexes with enhanced bioavailability
US10617700B1 (en) * 2016-02-26 2020-04-14 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
EP3338841A1 (en) * 2016-12-23 2018-06-27 Ferdinand Haschke Liquid human milk supplement
EP3618645A1 (en) * 2017-05-03 2020-03-11 Société des Produits Nestlé S.A. Whey protein extracts and their use as sphingomyelin source
AU2018363295A1 (en) * 2017-11-13 2020-07-02 Cancer Research Technology Ltd Dietary product
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN113194750A (zh) * 2018-12-21 2021-07-30 雀巢产品有限公司 用于在婴儿或幼儿中引起饱腹感、更好的睡眠和/或限制夜间觉醒的营养组合物
CN114401639A (zh) 2019-09-16 2022-04-26 雀巢产品有限公司 用钙强化的基于乳清的营养组合物
KR102536585B1 (ko) * 2020-08-04 2023-05-24 주식회사 엘지생활건강 액상 조제유 조성물
WO2022177965A1 (en) * 2021-02-16 2022-08-25 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
CN114568705B (zh) * 2022-03-22 2023-04-25 中国农业大学 一种有利于锌吸收的蛋白口服液及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
CA1243887A (en) 1984-07-03 1988-11-01 Shuryo Nakai REDUCING .beta.-LACTOGLOBULIN CONTENT IN WHEY PROTEIN CONCENTRATES FOR INFANT FORMULA USE
EP0368864B1 (en) 1987-05-14 1993-11-03 Commonwealth Scientific And Industrial Research Organisation Whey protein fractions
GB8723651D0 (en) 1987-10-08 1987-11-11 Express Foods Group Ltd Process for containing concentrates
US5436020A (en) 1990-02-19 1995-07-25 Meiji Milk Products Company Limited Method for producing a formulated milk for infants analogous to human milk
US5169666A (en) 1991-11-14 1992-12-08 The United States Of America As Represented By The Secretary Of Agriculture Preparation of simulated human milk protein by low temperature microfiltration
JP2622789B2 (ja) 1992-02-18 1997-06-18 雪印乳業株式会社 ホエーからα−ラクトアルブミン含有量の高い画分を製造する方法及び該画分を含有せしめてなる母乳代替物または栄養組成物
DK0604684T3 (da) 1992-12-23 1998-01-26 Campina Melkunie Bv Fremgangsmåde til genvinding af alphalactalbumin og betalactoglobulin fra et mælkeproteinprodukt
US6312755B1 (en) * 1999-07-16 2001-11-06 Ampc Whey treatment process for achieving high concentration of α-lactalbumin
WO2002028194A1 (en) 2000-10-05 2002-04-11 New Zealand Dairy Board Process for recovering proteins from whey protein containing feedstocks

Also Published As

Publication number Publication date
CN1646025A (zh) 2005-07-27
JP2005514017A (ja) 2005-05-19
ES2329667T3 (es) 2009-11-30
CA2471423A1 (en) 2003-07-10
CY1109503T1 (el) 2012-05-23
HK1065925A1 (en) 2005-03-11
AU2002357354B2 (en) 2008-11-20
NZ534041A (en) 2005-09-30
EP1455585A1 (en) 2004-09-15
EP1455585B1 (en) 2009-08-12
NO20043108L (no) 2004-09-06
SG169897A1 (en) 2011-04-29
JP4317455B2 (ja) 2009-08-19
TW200305371A (en) 2003-11-01
DK1455585T3 (da) 2009-12-07
CN101427802A (zh) 2009-05-13
ECSP045154A (es) 2004-07-23
US20030124237A1 (en) 2003-07-03
DE60233346D1 (de) 2009-09-24
US6913778B2 (en) 2005-07-05
EA200400849A1 (ru) 2004-10-28
IL162244A (en) 2010-02-17
TWI301052B (en) 2008-09-21
CN100456936C (zh) 2009-02-04
BR0215198A (pt) 2004-11-16
EA007148B1 (ru) 2006-08-25
CN101427802B (zh) 2012-08-01
UA81903C2 (uk) 2008-02-25
WO2003055322A1 (en) 2003-07-10
KR20040078650A (ko) 2004-09-10
ZA200405777B (en) 2007-12-27
IL162244A0 (en) 2005-11-20
CO5590862A2 (es) 2005-12-30
PT1455585E (pt) 2009-10-26
PL371379A1 (en) 2005-06-13
MXPA04005887A (es) 2004-09-13
KR100955408B1 (ko) 2010-05-06
ATE439044T1 (de) 2009-08-15
CA2471423C (en) 2012-02-21
AU2002357354A1 (en) 2003-07-15

Similar Documents

Publication Publication Date Title
AR037909A1 (es) Composiciones de formulaciones para lactantes que comprenden cantidades incrementadas de alfa-lactalbumina
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
BRPI0515316A (pt) compostos de imidazoquinolina
DK1377280T3 (da) Fyldmidler som mæthedsfornemmelsesgivende midler
DE60228235D1 (de) Tiernahrungszusammensetzung zur verbesserung der haut
BR9913343A (pt) Formulações de caseìna para a distribuição de constituintes bioativos
BR9908020A (pt) Fórmula para polimento ótico
BR9808948A (pt) Composição de confeitaria
BRPI0513500B8 (pt) uso de equivalentes de aspartato e composição nutricional ou farmacêutica
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
BRPI0600199A (pt) usos de ácido pinolênico ou um seu derivado e de uma composição
ATE286664T1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
ATE291856T1 (de) Neuartige, stabilisierte carotenoid-mischungen
BRPI0514411A (pt) formulação, e, método de produzir uma formulação
BR0309421A (pt) Composições de proteìna associada com corpo oleoso e métodos de uso destas para reduzir o risco de doença cardiovascular
BR9915353A (pt) Composições para modificação de adesão de superfìcie
ATE399558T1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
DK1589834T3 (da) Enteral komposition til forebyggelse og/eller behandling af sepsis
ATE481084T1 (de) Tensidhaltiges reinigungsmittel mit speziellen proteinen
ATE410402T1 (de) Feste mischungen von alpha- hydroxycarbonylderivaten von alpha- methylstyrololigomeren und deren verwendung
WO2005044244A3 (de) Verwendung von mrp4-inhibitoren zur behandlung und/oder prophylaxe kardiovaskulärer erkrankungen
BR0208554A (pt) Osteoprotegerina no leite
WO2006079121A3 (en) Methods of treating disease with glycosylated interferon
BR9809419A (pt) Combinação de antiácido e papaìna
IT244108Y1 (it) Dado in gabbia autofrenante di tipo perfezionato

Legal Events

Date Code Title Description
FG Grant, registration